
    
      This is a randomized, open, controlled and single-site clinical trail to investigate the
      effect and safety of Benaglutide or Metformin in patients with simple obesity who have
      inadequate weight control.

      Screening will be made to select eligible participants before intervention. Patients were
      randomly assigned to one of two groups(metformin or benaglutide) for therapies for 12 weeks
      including a two-week dose adjustment period and a 10-week dose stabilization period.
      Lifestyle interventions will be maintained during the treatment period. Subjects are followed
      up every 4 weeks for examinations.At the end of the study, data will be collected and
      analyzed.
    
  